Why it was recalled
Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.
Product description
Kian Pee Wan Capsules, 30-count bottles
Lot numbers, UPCs & expiration codes
All lots within expiry.
Where it was sold
Product was sold to individual consumers via ebay third party seller.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0769-2026
- Classification
- Class I
- Status
- Ongoing
- Recall initiated
- Mar 21, 2026
- FDA report date
- Aug 19, 2026
- Quantity
- 71 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Buy-Herbal
Original FDA data
Every field from FDA enforcement report D-0769-2026, exactly as published.
Show all FDA fields
- City
- Flushing
- State
- NY
- Status
- Ongoing
- Country
- United States
- Event ID
- 98650
- Address
- 13661 41st Ave
- Address (line 2)
- Box 239
- Code information
- All lots within expiry.
- Postal code
- 11355-2464
- Report date
- Aug 19, 2026
- Product type
- Drugs
- Recall number
- D-0769-2026
- Classification
- Class I
- Recalling firm
- Buy-Herbal
- Product quantity
- 71 bottles
- Reason for recall
- Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Kian Pee Wan Capsules, 30-count bottles
- Distribution pattern
- Product was sold to individual consumers via ebay third party seller.
- Recall initiation date
- Mar 21, 2026
- Initial firm notification
- Center classification date
- Aug 17, 2026